Page last updated: 2024-11-07

hydroxyacetylaminofluorene and Carcinoma, Hepatocellular

hydroxyacetylaminofluorene has been researched along with Carcinoma, Hepatocellular in 2 studies

Hydroxyacetylaminofluorene: A N-hydroxylated derivative of 2-ACETYLAMINOFLUORENE that has demonstrated carcinogenic action.

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Becker, FF2
Stout, DL1

Other Studies

2 other studies available for hydroxyacetylaminofluorene and Carcinoma, Hepatocellular

ArticleYear
Alteration of hepatocytes by subcarcinogenic exposure to n-2-fluorenylacetamide.
    Cancer research, 1975, Volume: 35, Issue:7

    Topics: Animals; Carcinoma, Hepatocellular; Chick Embryo; Chromosome Aberrations; Diet; Dimethylnitrosamine;

1975
Alteration of the ability of liver microsomes to activate N-2-fluorenylacetamide to a mutagen of Salmonella typhimurium during hepatocarcinogenesis.
    Cancer research, 1978, Volume: 38, Issue:8

    Topics: 2-Acetylaminofluorene; Animals; Carcinoma, Hepatocellular; Fluorenes; Hydroxyacetylaminofluorene; Li

1978